These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
488 related items for PubMed ID: 9214455
1. Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis. Matsuda Y, Matsumoto K, Yamada A, Ichida T, Asakura H, Komoriya Y, Nishiyama E, Nakamura T. Hepatology; 1997 Jul; 26(1):81-9. PubMed ID: 9214455 [Abstract] [Full Text] [Related]
2. Repeated intravenous injection of recombinant human hepatocyte growth factor ameliorates liver cirrhosis but causes albuminuria in rats. Kusumoto K, Ido A, Moriuchi A, Katsura T, Kim I, Takahama Y, Numata M, Kodama M, Hasuike S, Nagata K, Uto H, Inui K, Tsubouchi H. Int J Mol Med; 2006 Mar; 17(3):503-9. PubMed ID: 16465399 [Abstract] [Full Text] [Related]
3. Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats. Yasuda H, Imai E, Shiota A, Fujise N, Morinaga T, Higashio K. Hepatology; 1996 Sep; 24(3):636-42. PubMed ID: 8781336 [Abstract] [Full Text] [Related]
4. Anti-fibrotic effects of the anthocyanins isolated from the purple-fleshed sweet potato on hepatic fibrosis induced by dimethylnitrosamine administration in rats. Choi JH, Hwang YP, Choi CY, Chung YC, Jeong HG. Food Chem Toxicol; 2010 Nov; 48(11):3137-43. PubMed ID: 20728498 [Abstract] [Full Text] [Related]
5. Relationship between the proliferative capability of hepatocytes and the intrahepatic expression of hepatocyte growth factor and c-Met in the course of cirrhosis development in rats. Inoue H, Yokoyama F, Kita Y, Yoshiji H, Tsujimoto T, Deguchi A, Nakai S, Morishita A, Uchida N, Masaki T, Watanabe S, Kuriyama S. Int J Mol Med; 2006 May; 17(5):857-64. PubMed ID: 16596271 [Abstract] [Full Text] [Related]
6. Hepatocyte growth factor suppresses the onset of liver cirrhosis and abrogates lethal hepatic dysfunction in rats. Matsuda Y, Matsumoto K, Ichida T, Nakamura T. J Biochem; 1995 Sep; 118(3):643-9. PubMed ID: 8690730 [Abstract] [Full Text] [Related]
7. Effects of hepatotrophic factors on the liver after portacaval shunt in rats with portal hypertension. Zhang ZT, Jiang P, Wang Y, Li JS, Xue JG, Zhou YZ, Yuan Z. Chin Med J (Engl); 2006 Oct 20; 119(20):1727-33. PubMed ID: 17097021 [Abstract] [Full Text] [Related]
8. [Inhibitory effects of silymarin on hepatic fibrosis induced by dimethylnitrosamine: experiment with rats]. Zhao XY, Wang BE, Wang TL, Li XM. Zhonghua Yi Xue Za Zhi; 2006 Sep 26; 86(36):2563-6. PubMed ID: 17198567 [Abstract] [Full Text] [Related]
9. Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat. Abe W, Ikejima K, Lang T, Okumura K, Enomoto N, Kitamura T, Takei Y, Sato N. J Hepatol; 2007 Feb 26; 46(2):286-94. PubMed ID: 17166617 [Abstract] [Full Text] [Related]
10. Inhibition of transforming growth factor beta prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats. Nakamura T, Sakata R, Ueno T, Sata M, Ueno H. Hepatology; 2000 Aug 26; 32(2):247-55. PubMed ID: 10915731 [Abstract] [Full Text] [Related]
11. The flavonoid quercetin inhibits dimethylnitrosamine-induced liver damage in rats. Lee ES, Lee HE, Shin JY, Yoon S, Moon JO. J Pharm Pharmacol; 2003 Aug 26; 55(8):1169-74. PubMed ID: 12956909 [Abstract] [Full Text] [Related]
12. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Ueki T, Kaneda Y, Tsutsui H, Nakanishi K, Sawa Y, Morishita R, Matsumoto K, Nakamura T, Takahashi H, Okamoto E, Fujimoto J. Nat Med; 1999 Feb 26; 5(2):226-30. PubMed ID: 9930873 [Abstract] [Full Text] [Related]
13. Inhibitory effect of leflunomide on hepatic fibrosis induced by CCl4 in rats. Yao HW, Li J, Chen JQ, Xu SY. Acta Pharmacol Sin; 2004 Jul 26; 25(7):915-20. PubMed ID: 15210065 [Abstract] [Full Text] [Related]
14. Melatonin ameliorates carbon tetrachloride-induced hepatic fibrogenesis in rats via inhibition of oxidative stress. Wang H, Wei W, Wang NP, Gui SY, Wu L, Sun WY, Xu SY. Life Sci; 2005 Aug 26; 77(15):1902-15. PubMed ID: 15925388 [Abstract] [Full Text] [Related]
15. Potent antioxidant role of pirfenidone in experimental cirrhosis. Salazar-Montes A, Ruiz-Corro L, López-Reyes A, Castrejón-Gómez E, Armendáriz-Borunda J. Eur J Pharmacol; 2008 Oct 24; 595(1-3):69-77. PubMed ID: 18652820 [Abstract] [Full Text] [Related]
16. Effects and mechanisms of extract from Paeonia lactiflora and Astragalus membranaceus on liver fibrosis induced by carbon tetrachloride in rats. Sun WY, Wei W, Wu L, Gui SY, Wang H. J Ethnopharmacol; 2007 Jul 25; 112(3):514-23. PubMed ID: 17574357 [Abstract] [Full Text] [Related]
17. Portal branch ligation with a continuous hepatocyte growth factor supply makes extensive hepatectomy possible in cirrhotic rats. Kaido T, Yoshikawa A, Seto S, Yamaoka S, Sato M, Ishii T, Imamura M. Hepatology; 1998 Sep 25; 28(3):756-60. PubMed ID: 9731569 [Abstract] [Full Text] [Related]
18. The protective effects of a fermented substance from Saccharomyces cerevisiae on carbon tetrachloride-induced liver damage in rats. Lai JT, Hsieh WT, Fang HL, Lin WC. Clin Nutr; 2009 Jun 25; 28(3):338-45. PubMed ID: 19233522 [Abstract] [Full Text] [Related]
19. Effect of Anoectochilus formosanus on fibrosis and regeneration of the liver in rats. Shih CC, Wu YW, Hsieh CC, Lin WC. Clin Exp Pharmacol Physiol; 2004 Sep 25; 31(9):620-5. PubMed ID: 15479170 [Abstract] [Full Text] [Related]
20. Antifibrotic effects of tetrandrine on hepatic stellate cells and rats with liver fibrosis. Hsu YC, Chiu YT, Cheng CC, Wu CF, Lin YL, Huang YT. J Gastroenterol Hepatol; 2007 Jan 25; 22(1):99-111. PubMed ID: 17201889 [Abstract] [Full Text] [Related] Page: [Next] [New Search]